glp-1 agonists weight loss drugs market Exclusive Research Report 2025 Glucagon-Like Peptide (GLP)-1 Agonists Weight
Description
Newsome PN, Ambery P
Weaknesses The lack of required baseline lab work is concerning from a medical safety perspective
Other potential side effects might involve headaches, dizziness, fatigue, insomnia, and shifts in appetite
A., Yang, F
Data extraction An EndNote X9 (Clarivate Analytics, London, UK) library was initially created
Eur J Pharmacol (2020) 878:173102
